11q24.1 | HSPA8 | heat shock 70kDa protein 8 | 199 |
10q24.1 | FAS | Fas cell surface death receptor | 115 |
10q24-q25 | MXI1 | MAX interactor 1, dimerization protein | 90 |
19q13.3 | POLD1 | polymerase (DNA directed), delta 1, catalytic subunit | 118 |
15q22 | PML | promyelocytic leukemia | 96 |
13q14.2 | RB1 | retinoblastoma 1 | 120 |
14q13 | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 219 |
12p13 | FOXM1 | forkhead box M1 | 131 |
11p15.5 | IGF2 | insulin-like growth factor 2 | 29 |
10q24 | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 20 |
11q13 | BSCL2 | Berardinelli-Seip congenital lipodystrophy 2 (seipin) | 186 |
12q23.2 | IGF1 | insulin-like growth factor 1 (somatomedin C) | 28 |
1p13.1 | NGF | nerve growth factor (beta polypeptide) | 31 |
17p13.1 | TP53 | tumor protein p53 | 6 |
17q21-q22 | NGFR | nerve growth factor receptor | 37 |
19q13.3-q1 | BAX | BCL2-associated X protein | 119 |
19q13.2 | APOE | apolipoprotein E | 138 |
11p15.5 | HRAS | Harvey rat sarcoma viral oncogene homolog | 38 |
17q21 | BRCA1 | breast cancer 1, early onset | 61 |
19q13.3 | ERCC2 | excision repair cross-complementation group 2 | 11 |
10q22.2 | PLAU | plasminogen activator, urokinase | 10 |
14q32.33 | HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 74 |
17p12-p11. | UBB | ubiquitin B | 66 |
10q21.1 | CDK1 | cyclin-dependent kinase 1 | 201 |
17p13.3 | RPA1 | replication protein A1, 70kDa | 67 |
13q34 | IRS2 | insulin receptor substrate 2 | 34 |
11q12 | FEN1 | flap structure-specific endonuclease 1 | 114 |
12p13-p12. | RAD52 | RAD52 homolog, DNA repair protein | 147 |
17q21-q22 | TOP2A | topoisomerase (DNA) II alpha | 80 |
1q21 | SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 3 |
15q24.2 | SIN3A | SIN3 transcription regulator family member A | 200 |
1p32-p31 | JUN | jun proto-oncogene | 172 |
17q24-q25 | GRB2 | growth factor receptor-bound protein 2 | 122 |
14q11.2 | APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | 195 |
19p13 | PIN1 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 62 |
15q15.1 | RAD51 | RAD51 recombinase | 84 |
19p13.2 | EPOR | Erythropoietin receptor | 52 |
16q24.1 | PLCG2 | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 57 |
13q33 | ERCC5 | excision repair cross-complementation group 5 | 109 |
17q22-q23. | PRKCA | protein kinase C, alpha | 99 |
19p13.2 | JUND | jun D proto-oncogene | 45 |
10q11.23 | ERCC6 | excision repair cross-complementation group 6 | 92 |
11q22-q23 | ATM | ATM serine/threonine kinase | 9 |
16p12.3 | COQ7 | coenzyme Q7 homolog, ubiquinone (yeast) | 132 |
13q14.1 | FOXO1 | forkhead box O1 | 124 |
15q26.1 | BLM | Bloom syndrome, RecQ helicase-like | 68 |
13q12 | FLT1 | fms-related tyrosine kinase 1 | 171 |
13q12.3 | BRCA2 | breast cancer 2, early onset | 79 |
1q22 | LMNA | lamin A/C | 14 |
17q12 | MED1 | mediator complex subunit 1 | 173 |
11q13 | RELA | v-rel avian reticuloendotheliosis viral oncogene homolog A | 143 |
12q14.3-q1 | MDM2 | MDM2 proto-oncogene, E3 ubiquitin protein ligase | 210 |
11q13 | GSTP1 | glutathione S-transferase pi 1 | 157 |
16p11.2 | MAPK3 | mitogen-activated protein kinase 3 | 175 |
11p15.5 | INS | insulin | 30 |
19p13 | INSR | insulin receptor | 42 |
16q22.1 | TERF2 | telomeric repeat binding factor 2 | 116 |
19p13 | CACNA1A | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 133 |
14q23 | MAX | MYC associated factor X | 208 |
16p13.3 | UBE2I | ubiquitin-conjugating enzyme E2I | 85 |
13q34 | TFDP1 | transcription factor Dp-1 | 202 |
10q11.22 | MAPK8 | mitogen-activated protein kinase 8 | 163 |
11p13 | BDNF | brain-derived neurotrophic factor | 191 |
17q11.2 | STAT5B | signal transducer and activator of transcription 5B | 21 |
10q11.2 | RET | ret proto-oncogene | 56 |
13q12 | KL | klotho | 17 |
10q21.3 | SIRT1 | sirtuin 1 | 150 |
18q21.3 | BCL2 | B-cell CLL/lymphoma 2 | 69 |
14q32.32 | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 35 |
12q24 | PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 19 |
15q26.3 | IGF1R | insulin-like growth factor 1 receptor | 15 |
19p13.3 | EEF2 | eukaryotic translation elongation factor 2 | 103 |
17q24.2 | GH1 | growth hormone 1 | 26 |
14q23.2 | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 65 |
19q13.1 | TGFB1 | transforming growth factor, beta 1 | 91 |
12q13.1-q1 | DDIT3 | DNA-damage-inducible transcript 3 | 203 |
12p13.31 | A2M | alpha-2-macroglobulin | 139 |
11p13 | CAT | catalase | 107 |
17q12 | ERBB2 | erb-b2 receptor tyrosine kinase 2 | 41 |
13q12 | HMGB1 | high mobility group box 1 | 176 |
19p13.3 | STK11 | serine/threonine kinase 11 | 93 |
1q41-q42 | PARP1 | poly (ADP-ribose) polymerase 1 | 60 |
19p13.3 | TCF3 | transcription factor 3 | 59 |
1p31 | LEPR | leptin receptor | 218 |
14q24.3 | FOS | FBJ murine osteosarcoma viral oncogene homolog | 50 |
10p11.23 | BMI1 | BMI1 proto-oncogene, polycomb ring finger | 188 |
16p13.3 | CREBBP | CREB binding protein | 64 |
1q25.2-q25 | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 198 |
1q23.3 | SDHC | succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa | 182 |
10q23.3 | PTEN | phosphatase and tensin homolog | 63 |
12q13.1 | SP1 | Sp1 transcription factor | 170 |
19q13.32 | ERCC1 | excision repair cross-complementation group 1 | 149 |
12p13.31 | PEX5 | peroxisomal biogenesis factor 5 | 58 |
17q21.31 | STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 22 |
1p34 | HDAC1 | histone deacetylase 1 | 151 |
17q11.2 | STAT5A | signal transducer and activator of transcription 5A | 23 |
1p34.1 | PRDX1 | peroxiredoxin 1 | 141 |
17p11.2 | NCOR1 | nuclear receptor corepressor 1 | 43 |
11q23.3 | H2AFX | H2A histone family, member X | 212 |
17q21.3 | HOXB7 | homeobox B7 | 213 |
12q13.3 | HOXC4 | homeobox C4 | 214 |
10q24.2 | HELLS | helicase, lymphoid-specific | 101 |
15q25 | POLG | polymerase (DNA directed), gamma | 72 |
10q23.2-q2 | SNCG | synuclein, gamma (breast cancer-specific protein 1) | 140 |
15q15 | BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | 197 |
19q13.1 | CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 88 |
1p36.2 | MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 221 |
14q24.3 | PSEN1 | presenilin 1 | 224 |
19q13 | DLL3 | delta-like 3 (Drosophila) | 225 |
17q22 | NOG | noggin | 229 |
11q13 | PPP1CA | protein phosphatase 1, catalytic subunit, alpha isozyme | 227 |
17q21.1 | MAPT | microtubule-associated protein tau | 205 |
11q13.4 | UCP3 | uncoupling protein 3 (mitochondrial, proton carrier) | 232 |
1p34 | ZMPSTE24 | zinc metallopeptidase STE24 | 233 |
11q13 | UCP2 | uncoupling protein 2 (mitochondrial, proton carrier) | 235 |
1p22.1 | GCLM | glutamate-cysteine ligase, modifier subunit | 238 |
19p13.3 | SIRT6 | sirtuin 6 | 239 |
10q26 | BUB3 | BUB3 mitotic checkpoint protein | 240 |
12q23.2 | PMCH | pro-melanin-concentrating hormone | 242 |
16p13.3 | PDPK1 | 3-phosphoinositide dependent protein kinase 1 | 87 |
11q23.3 | APOC3 | apolipoprotein C-III | 102 |
16p13.3 | STUB1 | STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase | 245 |
17q23.2 | PPM1D | protein phosphatase, Mg2+/Mn2+ dependent, 1D | 246 |
11p11.2 | ARHGAP1 | Rho GTPase activating protein 1 | 249 |
1p36.1 | CDC42 | cell division cycle 42 | 250 |
11p15 | ARNTL | aryl hydrocarbon receptor nuclear translocator-like | 251 |
17p13.3 | HIC1 | hypermethylated in cancer 1 | 253 |
19p13.3 | GPX4 | glutathione peroxidase 4 | 257 |
12p13.3 | FGF23 | fibroblast growth factor 23 | 259 |
16p13.12 | ERCC4 | excision repair cross-complementation group 4 | 261 |
16q21 | CETP | cholesteryl ester transfer protein, plasma | 262 |
12p12.3 | EPS8 | epidermal growth factor receptor pathway substrate 8 | 267 |
1p13.3 | KCNA3 | potassium channel, voltage gated shaker related subfamily A, member 3 | 268 |
17q25 | SIRT7 | sirtuin 7 | 269 |
12q | SOCS2 | suppressor of cytokine signaling 2 | 271 |
13q32-q33 | TPP2 | tripeptidyl peptidase II | 273 |
15q15-q21 | TP53BP1 | tumor protein p53 binding protein 1 | 274 |
11p15.5 | SIRT3 | sirtuin 3 | 275 |
12q24 | NCOR2 | nuclear receptor corepressor 2 | 276 |
17q25.3 | PYCR1 | pyrroline-5-carboxylate reductase 1 | 280 |
1p36.3 | TP73 | tumor protein p73 | 281 |
1p36.12 | C1QA | complement component 1, q subcomponent, A chain | 287 |
16q13 | MT1E | metallothionein 1E | 292 |
19q13.33 | FGF21 | fibroblast growth factor 21 | 293 |
19q13.2 | GSK3A | glycogen synthase kinase 3 alpha | 295 |
17q21.32 | GRN | granulin | 300 |
1q42-q43 | SPRTN | SprT-like N-terminal domain | 302 |
16p11.2 | CTF1 | cardiotrophin 1 | 304 |
17p13.2 | TRPV1 | transient receptor potential cation channel subfamily V member 1 | 306 |
17q21.3 | NFE2L1 | nuclear factor, erythroid 2-like 1 | 307 |
16p13.3 | TRAP1 | TNF receptor-associated protein 1 | 305 |
12q13.2 | GDF11 | growth differentiation factor 11 | 309 |